Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Clinical trial NCT06511882 · RECRUITING
Trial details
- NCT number
- NCT06511882
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2027-10-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.